SCHEMBL14676154

SCHEMBL14676154

COc1cccc(S(=O)(=O)NC(C)(C)C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEP1B Q16820 1/20 0.54
PGR P06401 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
KEAP1 Q14145 2/20 0.51
NFE2L2 Q16236 2/20 0.51
FFAR4 Q5NUL3 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
POLB P06746 1/20 0.51
KAT6A Q92794 3/20 0.50
KDR P35968 2/20 0.49
RORA P35398 1/20 0.49
RORC P51449 1/20 0.49
NR1H2 P55055 1/20 0.49
FLT1 P17948 1/20 0.49
FLT4 P35916 1/20 0.49
AKR1C3 P42330 1/20 0.47
GAA P10253 1/20 0.47
ABCC9 O60706 1/20 0.46
ABCC8 Q09428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11209446 0.83 LMNA (0.65) MEP1BPGRKEAP1NFE2L2FFAR4
SCHEMBL6968304 0.82 MMP2 (0.57) ALDH1A1GAA
SCHEMBL14676410 0.81 KMT2A (0.53) ALDH1A1LMNA
SCHEMBL10402270 0.80 BCAT1 (0.50) L3MBTL1KEAP1ALDH1A1LMNAKAT6A
SCHEMBL14675852 0.79 MAPT (0.47) PGRLMNAKAT6AKDRGAA
SCHEMBL14675686 0.79 PGR (0.53) PGRLMNAKDRFLT1FLT4
SCHEMBL14677369 0.79 ATM (0.54) PGRALDH1A1LMNAKAT6AKDR
SCHEMBL24926381 0.78 PARG (0.55) MEP1BPGRL3MBTL1KEAP1NFE2L2
SCHEMBL14676933 0.77 GAA (0.53) L3MBTL1ALDH1A1GAA
SCHEMBL14677195 0.77 CA1 (0.61) PGRALDH1A1KAT6AGAAHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073830-B2 Compound for inhibiting 11β-hydroxy steroid dehydrogenase 1, and a pharmaceutical composition comprising the same HYUNDAI PHARM CO., LTD. (KR) 2015-07-07 US disclosed
US-20140206875-A1 A COMPOUND FOR INHIBITING 11B-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HYUNDAI PHARM CO., LTD. (KR) 2014-07-24 US disclosed
WO-2013019091-A2 A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HYUNDAI PHARM CO., LTD. (KR) 2013-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140206875-A1 A COMPOUND FOR INHIBITING 11B-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HSD11B1, HSD11B2, HSD17B1 MEP1B 725/4885PGR 961/4885L3MBTL1 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.